Skip to main content
OpenTrials

Clinical trial condition

Dermatitis, Atopic

Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.

1,192 public trials 150 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis, Atopic trial results

Completed

A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)

NCT05029895

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Takeo Skin Clinic /ID# 248095 Asahi Owari, Aichi-ken, Japan
  • Ichinomiya Municipal Hospital /ID# 245070 Ichinomiya-shi, Aichi-ken, Japan
  • NHO Nagoya Medical Center /ID# 245069 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 250809 Nagoya, Aichi-ken, Japan
View all 61 locations
View Trial Details
Completed

A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

NCT05369403

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • River Region Dermatology and Laser Montgomery, Alabama, United States
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • First OC Dermatology Fountain Valley, California, United States
  • Axon Clinical Research Inglewood, California, United States
View all 37 locations
View Trial Details
Completed

A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

NCT05923099

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • LEO Investigational Site Fountain Valley, California, United States
  • LEO Investigational Site Los Angeles, California, United States
  • LEO Investigational Site San Francisco, California, United States
  • LEO Investigational Site Hialeah, Florida, United States
View all 73 locations
View Trial Details
Completed

A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

NCT04541810

Conditions
Ankylosing Spondylitis (AS), Ankylosis, Arthritis, +30 more
Locations
  • Inje University - Busan Paik Hospital /ID# 259143 Busan, Busan Gwang Yeogsi, South Korea
  • Haeundae Bumin Hospital /ID# 238959 Busan, Busan Gwang Yeogsi, South Korea
  • Inje University Haeundae Hospital /ID# 238949 Busan, Busan Gwang Yeogsi, South Korea
  • Dong-A University Medical Center /ID# 269937 Busan, Busan Gwang Yeogsi, South Korea
View all 116 locations
View Trial Details
Completed

Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

NCT06283550

Conditions
Chronic Hand Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • INNO-6052 Site 12 Fredericton, New Brunswick, Canada
  • INNO-6052 Site 13 Cobourg, Ontario, Canada
  • INNO-6052 Site 11 Montreal, Quebec, Canada
  • INNO-6052 Site 19 Krakow, Poland
View Trial Details
Completed

Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)

NCT06945458

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Kymera Investigative Site Birmingham, Alabama, United States
  • Kymera Investigative Site Fountain Valley, California, United States
  • Kymera Investigative Site Santa Monica, California, United States
  • Kymera Investigative Site Boynton Beach, Florida, United States
View Trial Details

Related conditions